Raju Prasad

Stock Analyst at William Blair

(0)
# 5115
Out of 5,243 analysts
19
Total ratings
16.67%
Success rate
-51.08%
Average return
14 Stocks
Name Action Price Target Current % Upside Ratings Updated
Poseida Therapeutics
Downgrades: Market Perform
n/a
n/a n/a 1 Nov 26, 2024
Precision BioScience...
Downgrades: Market Perform
n/a
n/a n/a 1 Jun 9, 2022
Intellia Therapeutic...
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Feb 18, 2022
LogicBio Therapeutic...
Downgrades: Market Perform
n/a
n/a n/a 1 Feb 3, 2022
Global Blood Therape...
Upgrades: Outperform
n/a
n/a n/a 2 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Sep 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
92
5.42 1597.42% 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Mar 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
46
1.66 2671.08% 1 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
0.93 4738.71% 1 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 1 Mar 14, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Nov 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 2 Jun 18, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Aug 23, 2017